Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24780
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Anti-Inflammatory Agents/*administration & dosage,Antibodies, Monoclonal/*administration & dosage,Arthritis, Psoriatic/*drug therapy/*mortality,Delayed-Action Preparations,Dose-Response Relationship, Drug,Female,Follow-Up Studies,Greece/epidemiology,Humans,Incidence,Male,Middle Aged,Prevalence,Prospective Studies,Survival Rate/trends,Time Factors,Treatment Outcome,Tumor Necrosis Factor-alpha
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24780
ISSN: 0049-0172
Link: http://www.ncbi.nlm.nih.gov/pubmed/17888499
http://ac.els-cdn.com/S0049017207001217/1-s2.0-S0049017207001217-main.pdf?_tid=3db3ddde386d8fdba6987e3bf8490b64&acdnat=1333527124_01af6411e86a2e28966e45b09731f00e
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Voulgari-2008-Sustained clinical r.pdf510.52 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons